These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17365937)

  • 41. Changes in P-wave area and P-wave duration after circumferential pulmonary vein isolation.
    Van Beeumen K; Houben R; Tavernier R; Ketels S; Duytschaever M
    Europace; 2010 Jun; 12(6):798-804. PubMed ID: 20047928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis of P wave duration and dispersion in paroxysmal atrial fibrillation].
    Lelakowska-Pieła M; Pudło J; Engel A; Lelakowski J
    Pol Merkur Lekarski; 2013 Nov; 35(209):259-62. PubMed ID: 24575644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Target weight achievement and ultrafiltration rate thresholds: potential patient implications.
    Flythe JE; Assimon MM; Overman RA
    BMC Nephrol; 2017 Jun; 18(1):185. PubMed ID: 28578687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of P wave duration and dispersion in Parkinson's disease.
    Kocer A; Karakaya O; Barutcu I; Batukan Esen O; Kargin R; Mayda Domac F
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):718-23. PubMed ID: 16600454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of hemodialysis on P-wave signal-averaged electrocardiogram findings.
    Ozcan T; Horoz M; Genctoy G; Uyar B; Camsari A; Kiykim AA
    Artif Organs; 2007 Aug; 31(8):612-6. PubMed ID: 17651116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perindopril decreases P wave dispersion in patients with stage 1 hypertension.
    Ozben B; Sumerkan M; Tanrikulu AM; Papila-Topal N; Fak AS; Toprak A
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):85-90. PubMed ID: 19502255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Relationship Between Prolidase Activity and Atrial Electromechanical Changes in Patients with Paroxysmal Atrial Fibrillation.
    Tascanov MB
    Comb Chem High Throughput Screen; 2019; 22(1):69-75. PubMed ID: 30843482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.
    Fogari R; Derosa G; Ferrari I; Corradi L; Zoppi A; Lazzari P; Santoro T; Preti P; Mugellini A
    Am J Hypertens; 2008 Sep; 21(9):1034-9. PubMed ID: 18566593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioimpedance and the duration of the hemodialysis session.
    Basile C; Libutti P; Di Turo AL; Casucci F; Losurdo N; Teutonico A; Vernaglione L; Lomonte C
    ASAIO J; 2011; 57(4):310-3. PubMed ID: 21646906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy.
    Ozdemir O; Soylu M; Demir AD; Topaloglu S; Alyan O; Turhan H; Bicer A; Kutuk E
    Int J Cardiol; 2004 Apr; 94(2-3):163-6. PubMed ID: 15093974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrafiltration method for measuring vascular access flow rates during hemodialysis.
    Yarar D; Cheung AK; Sakiewicz P; Lindsay RM; Paganini EP; Steuer RR; Leypoldt JK
    Kidney Int; 1999 Sep; 56(3):1129-35. PubMed ID: 10469383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of P wave duration and dispersion with the risk for atrial fibrillation: practical considerations in the setting of coronary artery disease.
    Turgut O; Tandogan I; Yilmaz MB; Yalta K; Aydin O
    Int J Cardiol; 2010 Oct; 144(2):322-4. PubMed ID: 19285738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of ultrafiltration volume on blood volume changes during hemodialysis as observed in day-of-the-week analysis of hemodialysis sessions.
    Dasselaar JJ; de Jong PE; Huisman RM; Franssen CF
    ASAIO J; 2007; 53(4):479-84. PubMed ID: 17667235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between prescription of ultrafiltration and intradialytic hypotension in Chinese hemodialysis patients.
    Deng F; Di W; Ma Y; Li Y; Liao T; Mou J; Hong D; Wang W; Chen J; Jiang P; Li G; Mao J; Feng J
    Ann Palliat Med; 2021 May; 10(5):5316-5321. PubMed ID: 33977756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can a decreasing ultrafiltration profile affect the dialytic dose administered?
    Ramunni A; Brescia P; Ranieri G; Ria R; Coratelli P
    Ther Apher Dial; 2006 Oct; 10(5):463-6. PubMed ID: 17096702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.
    Gunes Y; Tuncer M; Guntekin U; Akdag S; Gumrukcuoglu HA
    Pacing Clin Electrophysiol; 2009 Feb; 32(2):239-44. PubMed ID: 19170914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodialysis-induced P-wave signal-averaged electrocardiogram alterations are indicative of vulnerability to atrial arrhythmias.
    Shimada K; Tomita T; Kamijo Y; Higuchi M; Ito K; Koizumi Y; Yamamoto K; Aizawa K; Koshikawa M; Kasai H; Izawa A; Miyashita Y; Kumazaki S; Koyama J; Ikeda U
    Circ J; 2012; 76(3):612-7. PubMed ID: 22240596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrafiltration profiling and measurement of relative blood volume as strategies to reduce hemodialysis-related side effects.
    Donauer J; Kölblin D; Bek M; Krause A; Böhler J
    Am J Kidney Dis; 2000 Jul; 36(1):115-23. PubMed ID: 10873880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ultrafiltration volume by once-weekly hemodialysis is a predictor of technique survival of combination therapy with peritoneal dialysis and hemodialysis.
    Tanaka M; Ishibashi Y; Hamasaki Y; Kamijo Y; Idei M; Nishi T; Takeda M; Nonaka H; Nangaku M; Mise N
    Ther Apher Dial; 2021 Feb; 25(1):82-87. PubMed ID: 32383342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.